The BIKEN Group is a Specialty Bio-Pharmaceutical Organization
specializing in Vaccines.
In 2017, the Research Foundation of Osaka University, BIKEN Foundation, and BIKEN Corporation started a new chapter known as the “BIKEN Group.”
We will combine our strengths and work for better public health both in Japan and the entire world.
Press Release & Update
Marketing Authorization Application of Pertussis, Diphtheria, Tetanus, Inactivated Polio and Hib Combined Vaccine (BK1310/MT-2355)
Regarding the Incident of Vaccine Culture Fluid Leakage at Seto Office
Establishment of Vaccine Manufacturing Joint Venture: BIKEN Co.,Ltd.
Basic Agreement on the Establishment of a Joint Venture
BIKEN begins development of Zika virus vaccine, upon concluding agreement on virus distribution with Chiba Prefectural Institute of Health
BIKEN additionally supports recovery efforts from The 2016 Kumamoto Earthquake